NO971361L - Fremgangsmåte for fremstilling av doseringsenheter ved våtgranulering - Google Patents

Fremgangsmåte for fremstilling av doseringsenheter ved våtgranulering

Info

Publication number
NO971361L
NO971361L NO971361A NO971361A NO971361L NO 971361 L NO971361 L NO 971361L NO 971361 A NO971361 A NO 971361A NO 971361 A NO971361 A NO 971361A NO 971361 L NO971361 L NO 971361L
Authority
NO
Norway
Prior art keywords
dosage units
wet granulation
preparing dosage
pharmaceutical dosage
preparing
Prior art date
Application number
NO971361A
Other languages
English (en)
Other versions
NO311492B1 (no
NO971361D0 (no
Inventor
Pieter De Haan
Jocominus Antonius Ma Zwinkels
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NO971361D0 publication Critical patent/NO971361D0/no
Publication of NO971361L publication Critical patent/NO971361L/no
Publication of NO311492B1 publication Critical patent/NO311492B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives en fremgangsmåte for fremstilling av farmasøy-tiske doseringsenheter som omfatter minst desogestrel eller Org 30659 (17a-17-hydroksy-ll-metylen-19-norpregna-4,15-dien-20-yn-3-on), til stede i en mengde av ca. 0,005 til 1,0 vekt% for hver farmasøytisk doseringsenhet, som erved at det steroide middel, og ved behov, farmasøytisk akseptable eksipienter, blandes med vann og granuleres.
NO19971361A 1994-09-22 1997-03-21 Fremgangsmåte for fremstilling av doseringsenheter omfattende ett steroid progestogen, ved våtgranulering, samt tabletter derav NO311492B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202728 1994-09-22
PCT/EP1995/003692 WO1996009056A1 (en) 1994-09-22 1995-09-19 Process of making dosage units by wet granulation

Publications (3)

Publication Number Publication Date
NO971361D0 NO971361D0 (no) 1997-03-21
NO971361L true NO971361L (no) 1997-05-21
NO311492B1 NO311492B1 (no) 2001-12-03

Family

ID=8217217

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971361A NO311492B1 (no) 1994-09-22 1997-03-21 Fremgangsmåte for fremstilling av doseringsenheter omfattende ett steroid progestogen, ved våtgranulering, samt tabletter derav

Country Status (22)

Country Link
US (1) US5916593A (no)
EP (1) EP0782449B1 (no)
JP (1) JP4334616B2 (no)
KR (1) KR100384264B1 (no)
CN (1) CN1101681C (no)
AT (1) ATE236639T1 (no)
AU (1) AU700645B2 (no)
BR (1) BR9509019B1 (no)
CA (1) CA2200754C (no)
CZ (1) CZ289081B6 (no)
DE (1) DE69530308T2 (no)
DK (1) DK0782449T3 (no)
ES (1) ES2196079T3 (no)
FI (1) FI118791B (no)
HU (1) HU226619B1 (no)
MX (1) MX9702162A (no)
NO (1) NO311492B1 (no)
NZ (1) NZ293606A (no)
PL (1) PL181406B1 (no)
PT (1) PT782449E (no)
RU (1) RU2166936C2 (no)
WO (1) WO1996009056A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955048A1 (en) * 1998-03-12 1999-11-10 Akzo Nobel N.V. Making dosage units using low shear granulation
IL128818A0 (en) * 1998-03-12 2000-01-31 Akzo Nobel Nv Making dosage units using low shear granulation
WO2000050041A1 (en) * 1999-02-24 2000-08-31 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose
EP1598069B1 (en) * 1999-08-31 2009-04-22 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
US20030027848A1 (en) * 2001-06-15 2003-02-06 Anne Billotte Stabilized formulations
DE60100389T2 (de) * 2001-07-11 2004-05-19 Apr Applied Pharma Research S.A. Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
GB0209265D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
NZ536273A (en) 2002-12-20 2007-08-31 Hoffmann La Roche High dose ibandronate formulation
RU2228747C1 (ru) * 2003-03-03 2004-05-20 Открытое акционерное общество "Щелковский витаминный завод" Антиангинальное средство пролонгированного действия
CZ298224B6 (cs) * 2003-04-29 2007-07-25 Pliva Istrazivanje I Razvoj D.O.O. Farmaceutická kompozice obsahující jako úcinnou látku ribavirin a zpusob její výroby
EP2409690B1 (en) * 2003-09-29 2022-11-09 Novo Nordisk Health Care AG Improved stability of progestogen formulations
PL1670440T3 (pl) * 2003-09-29 2014-11-28 Novo Nordisk Healthcare Ag Preparaty HRT
JP4412963B2 (ja) * 2003-10-10 2010-02-10 旭有機材工業株式会社 バルブ用樹脂製部材
EP1734930A2 (en) * 2004-04-09 2006-12-27 Smithkline Beecham Corporation Low dose pharmaceutical products
US7846466B2 (en) * 2004-06-10 2010-12-07 Northwestern University Biodegradable scaffolds and uses thereof
BRPI0516772A (pt) * 2004-10-25 2008-09-23 Japan Tobacco Inc formulação sólida com solubilidade e estabilidade melhoradas e método para produção da referida formulação
CN101128206A (zh) * 2005-01-21 2008-02-20 沃纳奇尔科特公司 固体剂型形式的四环素类金属络合物
NZ560232A (en) 2005-02-25 2010-11-26 Hoffmann La Roche Tablets with improved drug substance dispersibility
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
CN102083418A (zh) * 2008-04-24 2011-06-01 伊万斯彻有限公司 口服避孕药剂及其制备方法
MX2011001487A (es) * 2008-08-08 2011-03-30 Mcneil Ppc Inc Uso de sucralosa como agente granulante.
CN102176902B (zh) * 2008-10-09 2012-10-31 阿卜迪易卜拉欣贸易公司 有机溶剂在莫西沙星湿法造粒中的应用
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
JP2017001989A (ja) * 2015-06-11 2017-01-05 ニプロ株式会社 医薬組成物の製造方法及び医薬組成物
JP6759478B2 (ja) * 2019-02-13 2020-09-23 富士製薬工業株式会社 経口固形組成物、その製造方法、及びその製造方法によって得られた経口用錠剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969502A (en) * 1972-04-14 1976-07-13 Schering Aktiengesellschaft Method for contraception by the administration of sequential contraceptive preparations
GB2192128A (en) * 1986-07-03 1988-01-06 Fa Ez Khan Production of pharmaceutical unit dosage forms
US4956182A (en) * 1989-03-16 1990-09-11 Bristol-Myers Company Direct compression cholestyramine tablet and solvent-free coating therefor
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5098714A (en) * 1989-11-16 1992-03-24 Alza Corporation Osmotic, oral dosage form for fertility control
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
NZ262562A (en) * 1993-02-23 1996-04-26 Warner Lambert Co Preparation of solvent free pharmaceutical compositions
ZA941464B (en) * 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
PT782449E (pt) 2003-07-31
DE69530308T2 (de) 2003-10-16
US5916593A (en) 1999-06-29
PL319373A1 (en) 1997-08-04
EP0782449A1 (en) 1997-07-09
JP4334616B2 (ja) 2009-09-30
MX9702162A (es) 1997-06-28
FI118791B (fi) 2008-03-31
WO1996009056A1 (en) 1996-03-28
BR9509019B1 (pt) 2009-01-13
BR9509019A (pt) 1997-12-30
CZ89997A3 (en) 1997-09-17
JPH10505846A (ja) 1998-06-09
FI971172A0 (fi) 1997-03-20
DK0782449T3 (da) 2003-08-04
EP0782449B1 (en) 2003-04-09
AU700645B2 (en) 1999-01-14
KR970706001A (ko) 1997-11-03
CA2200754A1 (en) 1996-03-28
CN1161650A (zh) 1997-10-08
NO311492B1 (no) 2001-12-03
AU3608295A (en) 1996-04-09
DE69530308D1 (de) 2003-05-15
HK1002172A1 (en) 1998-08-07
FI971172L (fi) 1997-03-20
NZ293606A (en) 1998-06-26
CN1101681C (zh) 2003-02-19
CA2200754C (en) 2008-04-15
CZ289081B6 (cs) 2001-10-17
KR100384264B1 (ko) 2003-08-30
ATE236639T1 (de) 2003-04-15
HU226619B1 (en) 2009-04-28
ES2196079T3 (es) 2003-12-16
NO971361D0 (no) 1997-03-21
PL181406B1 (pl) 2001-07-31
RU2166936C2 (ru) 2001-05-20
HUT77611A (hu) 1998-06-29

Similar Documents

Publication Publication Date Title
NO971361D0 (no) Fremgangsmåte for fremstilling av doseringsenheter ved våtgranulering
RU97106339A (ru) Способ получения дозировочных единиц путем мокрой грануляции
ATE200733T1 (de) Pharmazeutische zubereitungen, die fluoxetin enthalten
DK1090029T3 (da) 14,15-Cyclopropansteroider fra 19-norandrostan-rækken, fremgangsmåde til deres fremstilling, og farmaceutiske præparater indeholdende disse forbindelser
NO982902D0 (no) FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen
NO953212L (no) Gepironholdig preparat
ATE70184T1 (de) Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung.
DK282784D0 (da) 1-alkyl-androsta-1,4-dien-3,17-dioner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem
ATE59960T1 (de) Theophyllintabletten mit verzoegerter freigabe.
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
ES2148493T3 (es) Nuevos compuestos con efecto analgesico y anestesico local.
NO992003D0 (no) Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
TR199900523T2 (xx) Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler.
NO992006D0 (no) Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
DK0937057T3 (da) Hidtil ukendte (-)-enantiomerer af cis-3,4-chromanderivater anvendelige i forebyggelse eller behandling af østrogenrelaterede sygdomme eller syndromer
NO900427L (no) Erosjonsregulert frigjoeringssystem for aktive stoffer og en fremgangsmaate for deres fremstilling.
TR199900013T2 (xx) Yeni bile�ikler.
RU97111373A (ru) Способ лечения заболеваний вирусной этиологии
NO308195B1 (no) Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF
NO992002L (no) Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer
NO974956L (no) Terapeutisk sammensetning for artritis
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer
JPS55160715A (en) Tablet having improved disintegrating property
Moon et al. REPRODUCTION STUDIES WITH PRANOPROFEN, A NONSTEROIDAL ANTI-INFLAMMATORY AGENT IN RATS-TERATOLOGY TEST
NO983650L (no) Krystallinske progestagener

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees